A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

This study tests the reliability and validity of the European Organization for Research and Treatment of Cancer (EORTC) head and neck cancer module (Q LQ-H&N35) and version 3.0 of the EORTC Core Questionnaire (QLQ-C30) in 622 head and neck cancer patients from 12 countries. The patients completed the QLQ-C30, the QLQ-H&N35 and a debriefing questionnaire before antineoplasti c treatment or at a follow-up. 232 patients receiving treatment completed a second questionnaire after treatment. Compliance was high and the question naire was well accepted by the patients. Multitrait scaling analysis confir med the proposed scale structure of the QLQ-H&N35. The QLQ-H&N35 was respon sive to differences between disease status, site and patients with differen t Karnofsky performance status, and to changes over time. The new physical functioning scale (with a four-point response format) of version 3.0 of the QLQ-C30 was shown to be more reliable than previous versions. Thus, the QL Q-H&N35, in conjunction with the VLQ-C30, appears to be reliable, valid and applicable to broad multicultural samples of head and neck cancer patients . (C) 2000 Elsevier Science Ltd. All rights reserved.